Impact of Mental Health in Georgia
May 06, 2022 1:00PM
Categories Biopharma & Therapeutics, Georgia Bio Event, Georgia Bio Events, Industry Partner Event, Industry Partner Events
A Discussion on Mental Health Awareness Month and Tardive Dyskinesia Awareness Week
Georgia Bio will host a legislative briefing on Friday, May 6th at 1 p.m. This event will feature a deep dive into the groundbreaking mental health legislation, House Bill 1013, passed during the 2022 session of the Georgia General Assembly, as well as highlight Tardive Dyskinesia Awareness Week, Mental Health Awareness Month, and additional patient protection measures that were passed.
– Rep. Sharon Cooper (R-Marietta), Chairman, House Health & Human Services
– Rep. Todd Jones (R-South Forsyth), HB 1013 Sponsor, Chairman, House Appropriations: Education Subcommittee
– Dr. Leslie Lundt, Clinical Psychiatrist and Executive Medical Director, Neurocrine Biosciences
– Kim Jones, National Alliance on Mental Illness (NAMI)
– Dorothy Leone-Glasser, Advocates for Responsible Care (ARxC)
This event is free to attend thanks to the generosity of our sponsor, Neurocrine Biosciences, but registration is required for access.
What is Tardive Dyskinesia?
TD is a condition that includes uncontrollable movements affecting the face, torso, and/or other body parts that may develop after a few months of taking certain medications (antipsychotics) to treat bipolar disorder, depression, schizophrenia, or schizoaffective disorder.